Literature DB >> 25349464

The expression of melanoma inhibitory activity on mast cells in child patients with cutaneous mastocytosis.

Yuko Ehara1, Yuichi Yoshida1, Makoto Tahira1, Osamu Yamamoto1.   

Abstract

BACKGROUND: Cutaneous mastocytosis is a disorder characterized by the proliferation of mast cells in the skin. Melanoma inhibitory activity (MIA) is a serum marker for malignant melanoma. However, it has not been known on MIA expression of cutaneous mastocytosis.
METHODS: We investigated the expression of MIA in 4 child patients with cutaneous mastocytosis immunohistochemically and serum MIA level in 1 patient by enzyme-linked immunosorbent assay.
RESULTS: Histopathological examination revealed diffuse mast cell infiltration in the dermis. MIA was positive for infiltrating mast cells in all patients. Serum level of MIA was elevated in 1 patient.
CONCLUSION: Although it was difficult to assess the significance of elevated serum levels of MIA in child patients, MIA was expressed on infiltrating mast cells in our study. Based on our findings, mast cell-derived MIA might be related to the formation of pigmented regions in cutaneous mastocytosis.

Entities:  

Keywords:  immunohistochemistry; mast cells; mastocytosis; melanocyte; melanoma inhibitory activity

Year:  2014        PMID: 25349464      PMCID: PMC4209339     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  11 in total

1.  Increased risk of malignant melanoma in patients with systemic mastocytosis?

Authors:  Hans Hägglund; Birgitta Sander; Theo Gülen; Bernt Lindelöf; Gunnar Nilsson
Journal:  Acta Derm Venereol       Date:  2014-09       Impact factor: 4.437

2.  SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.

Authors:  Saskia A Graf; Christian Busch; Anja-Katrin Bosserhoff; Robert Besch; Carola Berking
Journal:  J Invest Dermatol       Date:  2014-03-07       Impact factor: 8.551

3.  Elevated MIA levels in the serum of pregnant women and of children.

Authors:  A K Bosserhoff; H Küster; R Hein
Journal:  Clin Exp Dermatol       Date:  2004-11       Impact factor: 3.470

Review 4.  Update on diagnosis and treatment of mastocytosis.

Authors:  Knut Brockow; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

5.  Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma.

Authors:  A K Bosserhoff; M Kaufmann; B Kaluza; I Bartke; H Zirngibl; R Hein; W Stolz; R Buettner
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

6.  Functional role of MIA in melanocytes and early development of melanoma.

Authors:  Ina Poser; Jutta Tatzel; Silke Kuphal; Anja K Bosserhoff
Journal:  Oncogene       Date:  2004-08-12       Impact factor: 9.867

7.  Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.

Authors:  C Büttner; B M Henz; P Welker; N T Sepp; J Grabbe
Journal:  J Invest Dermatol       Date:  1998-12       Impact factor: 8.551

Review 8.  Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

Authors:  P Valent; C Akin; L Escribano; M Födinger; K Hartmann; K Brockow; M Castells; W R Sperr; H C Kluin-Nelemans; N A T Hamdy; O Lortholary; J Robyn; J van Doormaal; K Sotlar; A W Hauswirth; M Arock; O Hermine; A Hellmann; M Triggiani; M Niedoszytko; L B Schwartz; A Orfao; H-P Horny; D D Metcalfe
Journal:  Eur J Clin Invest       Date:  2007-06       Impact factor: 4.686

9.  Clinical correlates of blood serotonin levels in patients with mastocytosis.

Authors:  N M Kushnir-Sukhov; E Brittain; L Scott; D D Metcalfe
Journal:  Eur J Clin Invest       Date:  2008-12       Impact factor: 4.686

10.  Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.

Authors:  A Potier; C Lavigne; D Chappard; J L Verret; A Chevailler; B Nicolie; M Drouet
Journal:  Clin Exp Allergy       Date:  2009-03-10       Impact factor: 5.018

View more
  2 in total

Review 1.  Melanoma and Mastocytosis.

Authors:  Aleksandra Vojvodic; Tatjana Vlaskovic-Jovicevic; Petar Vojvodic; Jovana Vojvodic; Mohamad Goldust; Zorica Peric-Hajzler; Dusica Matovic; Goran Sijan; Nenad Stepic; Uwe Wollina; Massimo Fioranelli; Michael Tirant; Van Thuong Nguyen; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2019-08-30

Review 2.  Mastocytosis: from a Molecular Point of View.

Authors:  Daniel Elieh Ali Komi; Todd Rambasek; Stefan Wöhrl
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.